Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53.
Kaczorowski A, Tolstov Y, Falkenstein M, Vasioukhin V, Prigge ES, Geisler C, Kippenberger M, Nientiedt C, Ratz L, Kuryshev V, Herpel E, Kristiansen G, Sültmann H, Stenzinger A, Doeberitz MVK, Hohenfellner M, Duensing A, Duensing S.
Kaczorowski A, et al. Among authors: vasioukhin v.
Urol Oncol. 2020 Sep;38(9):736.e1-736.e10. doi: 10.1016/j.urolonc.2020.06.016. Epub 2020 Jul 13.
Urol Oncol. 2020.
PMID: 32674955
Free article.